A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session837f5ec1b9ca9ae5c945028bcbf1e611c2cc8dbd): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Serological Transplant Diagnostics Market Research Report 2024

img

Global Serological Transplant Diagnostics Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Serological Transplant Diagnostics Market Research Report 2024

Serological transplant diagnostics are used for all types of transplants. The products are developed based on the agglutination and complement fixation technology.
According to MRAResearch’s new survey, global Serological Transplant Diagnostics market is projected to reach US$ 405.7 million in 2033, increasing from US$ 345.5 million in 2022, with the CAGR of 2.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Serological Transplant Diagnostics market research.
Chronic kidney disease increases the risk of cardiovascular disease (CVD) and end-stage kidney renal disease (ESRD). The recent years witnessed a rise in the number of kidney transplantation procedures. The reduction in the average cost of gene sequencing will positively influence the growth of the human leukocyte antigen (HLA) typing market in the kidney transplantation segment. Additionally, the emergence of advanced serological diagnostic technologies will also boost the adoption of kidney transplantation procedures and will aid in serological transplant diagnostics market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Serological Transplant Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Bio-Rad Laboratories
Immucor
Siemens Healthineers
Ortho Clinical Diagnostics
Thermo Fisher Scientific
Agena Bioscience
AVIOQ
BAG Healthcare
BD
Beckman Coulter
Biogenuix
DIAGAST
Grifols
Hemo bioscience
Institut de Biotechnologies
Lorne Laboratories
MTC Invitro
Quotient Biodiagnostics
Tulip Group
Segment by Type
Kidney Transplantation
Liver Transplantation
Heart Transplantation
Lung Transplantation
Pancreas Transplantation

Segment by Application


Hospitals, Blood Banks and Transplant Centers
Donor Registries and Research Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Serological Transplant Diagnostics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Serological Transplant Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Kidney Transplantation
1.2.3 Liver Transplantation
1.2.4 Heart Transplantation
1.2.5 Lung Transplantation
1.2.6 Pancreas Transplantation
1.3 Market by Application
1.3.1 Global Serological Transplant Diagnostics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals, Blood Banks and Transplant Centers
1.3.3 Donor Registries and Research Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Serological Transplant Diagnostics Market Perspective (2018-2033)
2.2 Serological Transplant Diagnostics Growth Trends by Region
2.2.1 Global Serological Transplant Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Serological Transplant Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Serological Transplant Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 Serological Transplant Diagnostics Market Dynamics
2.3.1 Serological Transplant Diagnostics Industry Trends
2.3.2 Serological Transplant Diagnostics Market Drivers
2.3.3 Serological Transplant Diagnostics Market Challenges
2.3.4 Serological Transplant Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Serological Transplant Diagnostics Players by Revenue
3.1.1 Global Top Serological Transplant Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Serological Transplant Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Serological Transplant Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Serological Transplant Diagnostics Revenue
3.4 Global Serological Transplant Diagnostics Market Concentration Ratio
3.4.1 Global Serological Transplant Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Serological Transplant Diagnostics Revenue in 2022
3.5 Serological Transplant Diagnostics Key Players Head office and Area Served
3.6 Key Players Serological Transplant Diagnostics Product Solution and Service
3.7 Date of Enter into Serological Transplant Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Serological Transplant Diagnostics Breakdown Data by Type
4.1 Global Serological Transplant Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Serological Transplant Diagnostics Forecasted Market Size by Type (2024-2033)
5 Serological Transplant Diagnostics Breakdown Data by Application
5.1 Global Serological Transplant Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Serological Transplant Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Serological Transplant Diagnostics Market Size (2018-2033)
6.2 North America Serological Transplant Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Serological Transplant Diagnostics Market Size by Country (2018-2023)
6.4 North America Serological Transplant Diagnostics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Serological Transplant Diagnostics Market Size (2018-2033)
7.2 Europe Serological Transplant Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Serological Transplant Diagnostics Market Size by Country (2018-2023)
7.4 Europe Serological Transplant Diagnostics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Serological Transplant Diagnostics Market Size (2018-2033)
8.2 Asia-Pacific Serological Transplant Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Serological Transplant Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Serological Transplant Diagnostics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Serological Transplant Diagnostics Market Size (2018-2033)
9.2 Latin America Serological Transplant Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Serological Transplant Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Serological Transplant Diagnostics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Serological Transplant Diagnostics Market Size (2018-2033)
10.2 Middle East & Africa Serological Transplant Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Serological Transplant Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Serological Transplant Diagnostics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad Laboratories
11.1.1 Bio-Rad Laboratories Company Detail
11.1.2 Bio-Rad Laboratories Business Overview
11.1.3 Bio-Rad Laboratories Serological Transplant Diagnostics Introduction
11.1.4 Bio-Rad Laboratories Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.1.5 Bio-Rad Laboratories Recent Development
11.2 Immucor
11.2.1 Immucor Company Detail
11.2.2 Immucor Business Overview
11.2.3 Immucor Serological Transplant Diagnostics Introduction
11.2.4 Immucor Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.2.5 Immucor Recent Development
11.3 Siemens Healthineers
11.3.1 Siemens Healthineers Company Detail
11.3.2 Siemens Healthineers Business Overview
11.3.3 Siemens Healthineers Serological Transplant Diagnostics Introduction
11.3.4 Siemens Healthineers Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.3.5 Siemens Healthineers Recent Development
11.4 Ortho Clinical Diagnostics
11.4.1 Ortho Clinical Diagnostics Company Detail
11.4.2 Ortho Clinical Diagnostics Business Overview
11.4.3 Ortho Clinical Diagnostics Serological Transplant Diagnostics Introduction
11.4.4 Ortho Clinical Diagnostics Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.4.5 Ortho Clinical Diagnostics Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Serological Transplant Diagnostics Introduction
11.5.4 Thermo Fisher Scientific Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Agena Bioscience
11.6.1 Agena Bioscience Company Detail
11.6.2 Agena Bioscience Business Overview
11.6.3 Agena Bioscience Serological Transplant Diagnostics Introduction
11.6.4 Agena Bioscience Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.6.5 Agena Bioscience Recent Development
11.7 AVIOQ
11.7.1 AVIOQ Company Detail
11.7.2 AVIOQ Business Overview
11.7.3 AVIOQ Serological Transplant Diagnostics Introduction
11.7.4 AVIOQ Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.7.5 AVIOQ Recent Development
11.8 BAG Healthcare
11.8.1 BAG Healthcare Company Detail
11.8.2 BAG Healthcare Business Overview
11.8.3 BAG Healthcare Serological Transplant Diagnostics Introduction
11.8.4 BAG Healthcare Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.8.5 BAG Healthcare Recent Development
11.9 BD
11.9.1 BD Company Detail
11.9.2 BD Business Overview
11.9.3 BD Serological Transplant Diagnostics Introduction
11.9.4 BD Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.9.5 BD Recent Development
11.10 Beckman Coulter
11.10.1 Beckman Coulter Company Detail
11.10.2 Beckman Coulter Business Overview
11.10.3 Beckman Coulter Serological Transplant Diagnostics Introduction
11.10.4 Beckman Coulter Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.10.5 Beckman Coulter Recent Development
11.11 Biogenuix
11.11.1 Biogenuix Company Detail
11.11.2 Biogenuix Business Overview
11.11.3 Biogenuix Serological Transplant Diagnostics Introduction
11.11.4 Biogenuix Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.11.5 Biogenuix Recent Development
11.12 DIAGAST
11.12.1 DIAGAST Company Detail
11.12.2 DIAGAST Business Overview
11.12.3 DIAGAST Serological Transplant Diagnostics Introduction
11.12.4 DIAGAST Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.12.5 DIAGAST Recent Development
11.13 Grifols
11.13.1 Grifols Company Detail
11.13.2 Grifols Business Overview
11.13.3 Grifols Serological Transplant Diagnostics Introduction
11.13.4 Grifols Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.13.5 Grifols Recent Development
11.14 Hemo bioscience
11.14.1 Hemo bioscience Company Detail
11.14.2 Hemo bioscience Business Overview
11.14.3 Hemo bioscience Serological Transplant Diagnostics Introduction
11.14.4 Hemo bioscience Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.14.5 Hemo bioscience Recent Development
11.15 Institut de Biotechnologies
11.15.1 Institut de Biotechnologies Company Detail
11.15.2 Institut de Biotechnologies Business Overview
11.15.3 Institut de Biotechnologies Serological Transplant Diagnostics Introduction
11.15.4 Institut de Biotechnologies Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.15.5 Institut de Biotechnologies Recent Development
11.16 Lorne Laboratories
11.16.1 Lorne Laboratories Company Detail
11.16.2 Lorne Laboratories Business Overview
11.16.3 Lorne Laboratories Serological Transplant Diagnostics Introduction
11.16.4 Lorne Laboratories Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.16.5 Lorne Laboratories Recent Development
11.17 MTC Invitro
11.17.1 MTC Invitro Company Detail
11.17.2 MTC Invitro Business Overview
11.17.3 MTC Invitro Serological Transplant Diagnostics Introduction
11.17.4 MTC Invitro Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.17.5 MTC Invitro Recent Development
11.18 Quotient Biodiagnostics
11.18.1 Quotient Biodiagnostics Company Detail
11.18.2 Quotient Biodiagnostics Business Overview
11.18.3 Quotient Biodiagnostics Serological Transplant Diagnostics Introduction
11.18.4 Quotient Biodiagnostics Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.18.5 Quotient Biodiagnostics Recent Development
11.19 Tulip Group
11.19.1 Tulip Group Company Detail
11.19.2 Tulip Group Business Overview
11.19.3 Tulip Group Serological Transplant Diagnostics Introduction
11.19.4 Tulip Group Revenue in Serological Transplant Diagnostics Business (2018-2023)
11.19.5 Tulip Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Serological Transplant Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Kidney Transplantation
Table 3. Key Players of Liver Transplantation
Table 4. Key Players of Heart Transplantation
Table 5. Key Players of Lung Transplantation
Table 6. Key Players of Pancreas Transplantation
Table 7. Global Serological Transplant Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Serological Transplant Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Serological Transplant Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Serological Transplant Diagnostics Market Share by Region (2018-2023)
Table 11. Global Serological Transplant Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Serological Transplant Diagnostics Market Share by Region (2024-2033)
Table 13. Serological Transplant Diagnostics Market Trends
Table 14. Serological Transplant Diagnostics Market Drivers
Table 15. Serological Transplant Diagnostics Market Challenges
Table 16. Serological Transplant Diagnostics Market Restraints
Table 17. Global Serological Transplant Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Serological Transplant Diagnostics Market Share by Players (2018-2023)
Table 19. Global Top Serological Transplant Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Serological Transplant Diagnostics as of 2022)
Table 20. Ranking of Global Top Serological Transplant Diagnostics Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Serological Transplant Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Serological Transplant Diagnostics Product Solution and Service
Table 24. Date of Enter into Serological Transplant Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Serological Transplant Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Serological Transplant Diagnostics Revenue Market Share by Type (2018-2023)
Table 28. Global Serological Transplant Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Serological Transplant Diagnostics Revenue Market Share by Type (2024-2033)
Table 30. Global Serological Transplant Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Serological Transplant Diagnostics Revenue Market Share by Application (2018-2023)
Table 32. Global Serological Transplant Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Serological Transplant Diagnostics Revenue Market Share by Application (2024-2033)
Table 34. North America Serological Transplant Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Serological Transplant Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Serological Transplant Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Serological Transplant Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Serological Transplant Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Serological Transplant Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Serological Transplant Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Serological Transplant Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Serological Transplant Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Serological Transplant Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Serological Transplant Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Serological Transplant Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Serological Transplant Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Serological Transplant Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Serological Transplant Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 49. Bio-Rad Laboratories Company Detail
Table 50. Bio-Rad Laboratories Business Overview
Table 51. Bio-Rad Laboratories Serological Transplant Diagnostics Product
Table 52. Bio-Rad Laboratories Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 53. Bio-Rad Laboratories Recent Development
Table 54. Immucor Company Detail
Table 55. Immucor Business Overview
Table 56. Immucor Serological Transplant Diagnostics Product
Table 57. Immucor Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 58. Immucor Recent Development
Table 59. Siemens Healthineers Company Detail
Table 60. Siemens Healthineers Business Overview
Table 61. Siemens Healthineers Serological Transplant Diagnostics Product
Table 62. Siemens Healthineers Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 63. Siemens Healthineers Recent Development
Table 64. Ortho Clinical Diagnostics Company Detail
Table 65. Ortho Clinical Diagnostics Business Overview
Table 66. Ortho Clinical Diagnostics Serological Transplant Diagnostics Product
Table 67. Ortho Clinical Diagnostics Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 68. Ortho Clinical Diagnostics Recent Development
Table 69. Thermo Fisher Scientific Company Detail
Table 70. Thermo Fisher Scientific Business Overview
Table 71. Thermo Fisher Scientific Serological Transplant Diagnostics Product
Table 72. Thermo Fisher Scientific Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 73. Thermo Fisher Scientific Recent Development
Table 74. Agena Bioscience Company Detail
Table 75. Agena Bioscience Business Overview
Table 76. Agena Bioscience Serological Transplant Diagnostics Product
Table 77. Agena Bioscience Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 78. Agena Bioscience Recent Development
Table 79. AVIOQ Company Detail
Table 80. AVIOQ Business Overview
Table 81. AVIOQ Serological Transplant Diagnostics Product
Table 82. AVIOQ Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 83. AVIOQ Recent Development
Table 84. BAG Healthcare Company Detail
Table 85. BAG Healthcare Business Overview
Table 86. BAG Healthcare Serological Transplant Diagnostics Product
Table 87. BAG Healthcare Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 88. BAG Healthcare Recent Development
Table 89. BD Company Detail
Table 90. BD Business Overview
Table 91. BD Serological Transplant Diagnostics Product
Table 92. BD Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 93. BD Recent Development
Table 94. Beckman Coulter Company Detail
Table 95. Beckman Coulter Business Overview
Table 96. Beckman Coulter Serological Transplant Diagnostics Product
Table 97. Beckman Coulter Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 98. Beckman Coulter Recent Development
Table 99. Biogenuix Company Detail
Table 100. Biogenuix Business Overview
Table 101. Biogenuix Serological Transplant Diagnostics Product
Table 102. Biogenuix Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 103. Biogenuix Recent Development
Table 104. DIAGAST Company Detail
Table 105. DIAGAST Business Overview
Table 106. DIAGAST Serological Transplant Diagnostics Product
Table 107. DIAGAST Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 108. DIAGAST Recent Development
Table 109. Grifols Company Detail
Table 110. Grifols Business Overview
Table 111. Grifols Serological Transplant Diagnostics Product
Table 112. Grifols Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 113. Grifols Recent Development
Table 114. Hemo bioscience Company Detail
Table 115. Hemo bioscience Business Overview
Table 116. Hemo bioscience Serological Transplant Diagnostics Product
Table 117. Hemo bioscience Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 118. Hemo bioscience Recent Development
Table 119. Institut de Biotechnologies Company Detail
Table 120. Institut de Biotechnologies Business Overview
Table 121. Institut de Biotechnologies Serological Transplant Diagnostics Product
Table 122. Institut de Biotechnologies Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 123. Institut de Biotechnologies Recent Development
Table 124. Lorne Laboratories Company Detail
Table 125. Lorne Laboratories Business Overview
Table 126. Lorne Laboratories Serological Transplant Diagnostics Product
Table 127. Lorne Laboratories Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 128. Lorne Laboratories Recent Development
Table 129. MTC Invitro Company Detail
Table 130. MTC Invitro Business Overview
Table 131. MTC Invitro Serological Transplant Diagnostics Product
Table 132. MTC Invitro Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 133. MTC Invitro Recent Development
Table 134. Quotient Biodiagnostics Company Detail
Table 135. Quotient Biodiagnostics Business Overview
Table 136. Quotient Biodiagnostics Serological Transplant Diagnostics Product
Table 137. Quotient Biodiagnostics Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 138. Quotient Biodiagnostics Recent Development
Table 139. Tulip Group Company Detail
Table 140. Tulip Group Business Overview
Table 141. Tulip Group Serological Transplant Diagnostics Product
Table 142. Tulip Group Revenue in Serological Transplant Diagnostics Business (2018-2023) & (US$ Million)
Table 143. Tulip Group Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Serological Transplant Diagnostics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Serological Transplant Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. Kidney Transplantation Features
Figure 4. Liver Transplantation Features
Figure 5. Heart Transplantation Features
Figure 6. Lung Transplantation Features
Figure 7. Pancreas Transplantation Features
Figure 8. Global Serological Transplant Diagnostics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Serological Transplant Diagnostics Market Share by Application: 2022 VS 2033
Figure 10. Hospitals, Blood Banks and Transplant Centers Case Studies
Figure 11. Donor Registries and Research Laboratories Case Studies
Figure 12. Serological Transplant Diagnostics Report Years Considered
Figure 13. Global Serological Transplant Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Serological Transplant Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Serological Transplant Diagnostics Market Share by Region: 2022 VS 2033
Figure 16. Global Serological Transplant Diagnostics Market Share by Players in 2022
Figure 17. Global Top Serological Transplant Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Serological Transplant Diagnostics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Serological Transplant Diagnostics Revenue in 2022
Figure 19. North America Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Serological Transplant Diagnostics Market Share by Country (2018-2033)
Figure 21. United States Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Serological Transplant Diagnostics Market Share by Country (2018-2033)
Figure 25. Germany Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Serological Transplant Diagnostics Market Share by Region (2018-2033)
Figure 33. China Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Serological Transplant Diagnostics Market Share by Country (2018-2033)
Figure 41. Mexico Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Serological Transplant Diagnostics Market Share by Country (2018-2033)
Figure 45. Turkey Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Serological Transplant Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Bio-Rad Laboratories Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 48. Immucor Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 49. Siemens Healthineers Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 50. Ortho Clinical Diagnostics Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 52. Agena Bioscience Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 53. AVIOQ Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 54. BAG Healthcare Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 55. BD Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 56. Beckman Coulter Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 57. Biogenuix Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 58. DIAGAST Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 59. Grifols Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 60. Hemo bioscience Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 61. Institut de Biotechnologies Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 62. Lorne Laboratories Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 63. MTC Invitro Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 64. Quotient Biodiagnostics Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 65. Tulip Group Revenue Growth Rate in Serological Transplant Diagnostics Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed